RecruitingPhase not listedNCT04846959
Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
Sponsor: AbbVie
Morrisville, NC · Wilmington, NC